mitotane has been researched along with triiodothyronine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cheban, AK; Kommisarenko, IV; Luchitskiĭ, EV; Slavnov, VN | 1 |
Ambrosio, MR; Carandina, G; Daffara, F; Degli Uberti, EC; Gentilin, E; Reimondo, G; Tagliati, F; Terzolo, M; Zatelli, MC | 1 |
Cannavò, S; Cotta, OR; Frasca, F; Gullo, D; Pellegriti, G; Russo, M; Scollo, C; Squatrito, S | 1 |
1 review(s) available for mitotane and triiodothyronine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for mitotane and triiodothyronine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Hypothalamo-hypophyseal-thyroid relationship in patients with Itsenko-Cushing disease treated with chloditan].
Topics: Adolescent; Adult; Cushing Syndrome; Female; Humans; Hypothalamo-Hypophyseal System; Male; Middle Aged; Mitotane; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 1978 |
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model.
Topics: Animals; Antineoplastic Agents, Hormonal; Cell Survival; Enzyme-Linked Immunosorbent Assay; Humans; Mice; Mitotane; Reverse Transcriptase Polymerase Chain Reaction; Thyrotrophs; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 2010 |
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism.
Topics: Adrenal Cortex Neoplasms; Adult; Aged; Antineoplastic Agents, Hormonal; Female; Humans; Hypothyroidism; Middle Aged; Mitotane; Retrospective Studies; Thyroid Function Tests; Thyrotropin; Thyroxine; Triiodothyronine | 2016 |